71
Participants
Start Date
June 14, 2021
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
Buprenorphine Injection
Weekly and monthly formulations of injectable, extended-release buprenorphine (BUP-XR).
Buprenorphine Sublingual Product
Sublingual buprenorphine (BUP-SL), administered daily.
Pregnancy Recovery Center at Magee-Womens Hospital of UPMC, Pittsburgh
Marshall Health MARC Program, Huntington
Medical University of South Carolina, Charleston
Gateway Community Services, Jacksonville
Vanderbilt University Medical Center, Nashville
University of Utah SUPeRAD Clinic, Salt Lake City
CODA, Inc., Portland
Addiction Recovery Services (ARS), Swedish Medical Center, Seattle
Massachusetts General Hospital HOPE Clinic, Boston
Boston Medical Center, Boston
National Institute on Drug Abuse (NIDA)
NIH
The Emmes Company, LLC
INDUSTRY
T. John Winhusen, PhD
OTHER